Detalles de la búsqueda
1.
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer.
J Transl Med
; 17(1): 137, 2019 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31036005
2.
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases.
J Transl Med
; 15(1): 91, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28460632
3.
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
Acta Oncol
; 56(7): 1013-1020, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28431480
4.
The Italian Experience in the Development of Mesothelioma Registries: A Pathway for Other Countries to Address the Negative Legacy of Asbestos.
Int J Environ Res Public Health
; 20(2)2023 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36673690
5.
Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma.
Front Oncol
; 11: 660039, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34249695
6.
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score.
Diagnostics (Basel)
; 11(11)2021 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34829362
7.
A feasibility exploratory study of a novel modality of using patient-reported outcomes (PROsEXPLOR) in the real world.
Tumori
; 106(6): 464-470, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32432979
8.
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.
J Immunother Cancer
; 8(2)2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33060148
9.
Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials.
Clin Cancer Res
; 25(5): 1479-1485, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765389
10.
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.
Eur J Cancer
; 87: 147-163, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29149761
11.
Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
Eur J Cancer
; 64: 44-51, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27323349
12.
A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 'CREATE' trial.
Eur J Cancer
; 109: 192-195, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30655100
Resultados
1 -
12
de 12
1
Próxima >
>>